Andere talen DongKook Pharmaceutical Co., Ltd.

Aandelen

A086450

KR7086450004

slotkoers Korea S.E. Andere beurzen 00:00:00 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
17.700 ^KRW	+2,25%		+4,12%	+9,53%

14/03	DongKook Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	DongKook Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11-08-23
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14-11-22
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16-05-22
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine	12-04-22
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	17-03-22
DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15-11-21
YJM Games Co., Ltd. announced that it has received KRW 7.5 billion in funding from HisStory Investment Management, DongKook Pharmaceutical Co., Ltd.	18-08-21
YJM Games Co., Ltd. announced that it expects to receive KRW 7.5 billion in funding from HisStory Investment Management, DongKook Pharmaceutical Co., Ltd., and other investors	11-08-21
Hanchang Corporation announced that it has received KRW 5 billion in funding from MAGNA Investment Co., Ltd., Axis Investment Co., Ltd., DongKook Pharmaceutical Co., Ltd., Jinhaksa Corporation	28-12-20
Hanchang Corporation announced that it expects to receive KRW 5 billion in funding from MAGNA Investment Co., Ltd., Axis Investment Co., Ltd., DongKook Pharmaceutical Co., Ltd., Jinhaksa Corporation	23-12-20
DongKook Pharmaceutical Co., Ltd. announced that it has received KRW 10.0000516 billion in funding	18-07-18
DongKook Pharmaceutical Co., Ltd. announced that it expects to receive KRW 10.0000516 billion in funding	03-07-18
GS Instruments Co. Ltd. announced that it has received KRW 3 billion in funding from DONGKOOK Pharmaceutical Co., Ltd., Unione Communications Co., Ltd., GS Teletech Co., Ltd., and other investors.	03-05-16
GS Instruments Co. Ltd. announced that it expects to receive KRW 3 billion in funding from DONGKOOK Pharmaceutical Co., Ltd., Unione Communications Co., Ltd., GS Teletech Co., Ltd., and other investors.	06-04-16
DONGKOOK Pharmaceutical Co., Ltd.'s Equity Buyback announced on March 13, 2015 has expired.	13-09-15
DONGKOOK Pharmaceutical Co., Ltd.(KOSDAQ:A086450) added to Russell Global Index	29-06-15
Tranche Update on DONGKOOK Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 13, 2015.	16-06-15

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen DongKook Pharmaceutical Co., Ltd.

Aandelen

A086450

KR7086450004

Andere talen

Filters